Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-07-24 Sale | 2024-07-26 4:52 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 7,772 | $18.06 | $140,360 | 107,571 (Direct) | View |
2024-07-18 Sale | 2024-07-19 4:09 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 12,625 | $18.2 | $229,804 | 57,772 (Direct) | View |
2024-07-12 Sale | 2024-07-16 4:46 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,189 | $18.02 | $165,578 | 146,695 (Direct) | View |
2024-07-01 Sale | 2024-07-03 1:12 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 912 | $18.01 | $16,428 | 159,209 (Direct) | View |
2024-06-24 Sale | 2024-06-26 4:26 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,260 | $18.19 | $168,427 | 80,498 (Direct) | View |
2024-06-11 Sale | 2024-06-13 4:46 pm | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 1,586 | $18.06 | $28,637 | 180,602 (Direct) | View |
2024-06-05 Sale | 2024-06-07 4:12 pm | PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development | 8,656 | $18.08 | $156,460 | 184,099 (Direct) | View |
2024-05-17 Sale | 2024-05-17 8:51 pm | PepGen Inc. | PEPG | Svenstrup Niels SVP, Chem. Mfg & Controls | 10,000 | $13.41 | $134,100 | 0 (Direct) | View |
2022-05-10 Purchase(A) | 2024-04-09 5:24 pm | PepGen Inc. | PEPG | Oxford Science Enterprises plc 10% Owner | 879,970 | $12 | $10,559,640 | 4,755,388 (Direct) | View |
2024-02-09 Purchase | 2024-02-13 4:33 pm | PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 2,557,593 | $10.64 | $27,212,790 | 10,689,545 (Indirect) | View |
2023-11-30 Purchase | 2023-12-05 07:34 am | PepGen Inc. | PEPG | McArthur James G President and CEO | 1,694 | $4.165 | $7,056 | 1,694 (Direct) | View |
2023-06-08 Sale | 2023-06-09 7:06 pm | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,381 | $16.04 | $38,188 | 325,054 (Direct) | View |
2023-06-06 Sale | 2023-06-08 5:23 pm | PepGen Inc. | PEPG | McArthur James G President and CEO | 26,569 | $16.19 | $430,277 | 663,289 (Direct) | View |
2023-06-02 Sale | 2023-06-06 4:19 pm | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,300 | $16.04 | $36,891 | 708,508 (Direct) | View |
2023-03-24 Sale | 2023-03-28 7:36 pm | PepGen Inc. | PEPG | Goyal Jaya EVP, Res. & Preclin. Dev. | 392 | $20 | $7,840 | 143,804 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-19 Option Award | 2024-08-20 4:28 pm | 2025-08-19 2034-08-18 | PepGen Inc. | PEPG | STRECK PAUL EVP, Head of R&D | 242,816 | $0 | 445,632 (Direct) | View |
2024-07-24 Exercise | 2024-07-26 4:52 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 7,772 | $0 | 107,571 (Direct) | View |
2024-07-24 Exercise | 2024-07-26 4:52 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 7,772 | $10.21 | 107,571 (Direct) | View |
2024-07-18 Exercise | 2024-07-19 4:09 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 12,625 | $0 | 57,772 (Direct) | View |
2024-07-18 Exercise | 2024-07-19 4:09 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 12,625 | $10.21 | 57,772 (Direct) | View |
2024-07-12 Exercise | 2024-07-16 4:46 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,189 | $0 | 146,695 (Direct) | View |
2024-07-12 Exercise | 2024-07-16 4:46 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,189 | $10.21 | 146,695 (Direct) | View |
2024-07-01 Exercise | 2024-07-03 1:12 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 912 | $0 | 159,209 (Direct) | View |
2024-07-01 Exercise | 2024-07-03 1:12 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 912 | $10.21 | 159,209 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:26 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,260 | $0 | 80,498 (Direct) | View |
2024-06-24 Exercise | 2024-06-26 4:26 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 9,260 | $10.21 | 80,498 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:14 pm | N/A 2034-06-19 | PepGen Inc. | PEPG | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 13,000 | $0 | 13,000 (Indirect) | View |
2024-06-20 Option Award | 2024-06-21 4:11 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | HENSON HEIDI Director | 13,000 | $0 | 13,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:10 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | KEATING LAURIE Director | 13,000 | $0 | 13,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:09 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | Resnick Joshua Director | 13,000 | $0 | 13,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:08 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | Ashton Christopher Director | 13,000 | $0 | 13,000 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:04 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | Mayer Howard Director | 8,667 | $0 | 8,667 (Direct) | View |
2024-06-20 Option Award | 2024-06-21 4:03 pm | 2025-06-20 2034-06-19 | PepGen Inc. | PEPG | Dable Habib J Director | 13,000 | $0 | 13,000 (Direct) | View |
2024-06-11 Exercise | 2024-06-13 4:46 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 1,586 | $0 | 180,602 (Direct) | View |
2024-06-11 Exercise | 2024-06-13 4:46 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L Chief Medical Officer | 1,586 | $10.21 | 180,602 (Direct) | View |
2024-06-05 Exercise | 2024-06-07 4:12 pm | N/A 2032-06-30 | PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development | 8,656 | $0 | 184,099 (Direct) | View |
2024-06-05 Exercise | 2024-06-07 4:12 pm | N/A N/A | PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development | 8,656 | $10.21 | 184,099 (Direct) | View |
2024-03-01 Option Award | 2024-03-01 5:49 pm | 2025-03-01 2034-02-28 | PepGen Inc. | PEPG | Svenstrup Niels SVP, Chem. Mfg & Controls | 83,000 | $0 | 83,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-01 5:38 pm | 2025-03-01 2034-02-28 | PepGen Inc. | PEPG | McArthur James G President and CEO | 300,000 | $0 | 300,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-01 5:33 pm | 2025-03-01 2034-02-28 | PepGen Inc. | PEPG | Donnelly Noel Chief Financial Officer | 144,000 | $0 | 144,000 (Direct) | View |
2024-03-01 Option Award | 2024-03-01 5:29 pm | 2025-03-01 2034-02-28 | PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development | 83,000 | $0 | 83,000 (Direct) | View |
2024-01-15 Option Award | 2024-01-17 4:26 pm | 2025-01-15 2034-01-14 | PepGen Inc. | PEPG | DeLena Mary Beth General Counsel | 125,000 | $0 | 125,000 (Direct) | View |
2023-11-10 Option Award | 2023-11-14 7:11 pm | 2024-11-10 2033-11-09 | PepGen Inc. | PEPG | Mayer Howard Director | 22,686 | $0 | 22,686 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 4:16 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | Ashton Christopher Director | 12,000 | $0 | 12,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 4:14 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | Resnick Joshua Director | 12,000 | $0 | 12,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 4:13 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | KEATING LAURIE Director | 12,000 | $0 | 12,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 4:11 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | HENSON HEIDI Director | 12,000 | $0 | 12,000 (Direct) | View |
2023-06-22 Option Award | 2023-06-26 4:00 pm | 2024-06-22 2033-06-21 | PepGen Inc. | PEPG | Dable Habib J Director | 9,000 | $0 | 9,000 (Direct) | View |
2023-06-08 Exercise | 2023-06-09 7:06 pm | N/A 2031-03-21 | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,381 | $0 | 325,054 (Direct) | View |
2023-06-08 Exercise | 2023-06-09 7:06 pm | N/A N/A | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,381 | $2.71 | 325,054 (Direct) | View |
2023-06-06 Exercise | 2023-06-08 5:23 pm | N/A 2031-03-21 | PepGen Inc. | PEPG | McArthur James G President and CEO | 26,569 | $0 | 663,289 (Direct) | View |
2023-06-06 Exercise | 2023-06-08 5:23 pm | N/A N/A | PepGen Inc. | PEPG | McArthur James G President and CEO | 26,569 | $2.71 | 663,289 (Direct) | View |
2023-06-02 Exercise | 2023-06-06 4:19 pm | N/A 2031-03-21 | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,300 | $0 | 708,508 (Direct) | View |
2023-06-02 Exercise | 2023-06-06 4:19 pm | N/A N/A | PepGen Inc. | PEPG | McArthur James G President and CEO | 2,300 | $2.71 | 708,508 (Direct) | View |
2023-03-24 Exercise | 2023-03-28 7:36 pm | N/A 2031-11-10 | PepGen Inc. | PEPG | Goyal Jaya EVP, Res. & Preclin. Dev. | 392 | $0 | 143,804 (Direct) | View |
2023-03-24 Exercise | 2023-03-28 7:36 pm | N/A N/A | PepGen Inc. | PEPG | Goyal Jaya EVP, Res. & Preclin. Dev. | 392 | $10.88 | 143,804 (Direct) | View |
2023-03-01 Option Award | 2023-03-02 4:53 pm | 2024-03-01 2033-02-28 | PepGen Inc. | PEPG | Mellion Michelle L SVP, Clinical Development | 95,000 | $0 | 170,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-02 4:46 pm | 2024-03-01 2033-02-28 | PepGen Inc. | PEPG | Goyal Jaya EVP, Res. & Preclin. Dev. | 75,000 | $0 | 75,000 (Direct) | View |
2023-03-01 Option Award | 2023-03-02 4:42 pm | 2024-03-01 2033-02-28 | PepGen Inc. | PEPG | Svenstrup Niels SVP, Chem. Mfg & Controls | 75,000 | $0 | 75,000 (Direct) | View |